Compare AMT & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMT | GSK |
|---|---|---|
| Founded | 1995 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8B | 95.3B |
| IPO Year | 1998 | N/A |
| Metric | AMT | GSK |
|---|---|---|
| Price | $174.74 | $48.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | ★ $230.13 | N/A |
| AVG Volume (30 Days) | 3.1M | ★ 4.2M |
| Earning Date | 10-28-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.81% | 3.41% |
| EPS Growth | ★ 164.45 | 118.57 |
| EPS | ★ 6.27 | 1.79 |
| Revenue | $10,454,700,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $5.56 | $6.56 |
| Revenue Next Year | $3.74 | $5.13 |
| P/E Ratio | $28.48 | ★ $27.27 |
| Revenue Growth | ★ 4.17 | 2.73 |
| 52 Week Low | $172.51 | $31.72 |
| 52 Week High | $234.33 | $49.44 |
| Indicator | AMT | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 37.16 | 54.99 |
| Support Level | $177.91 | $48.52 |
| Resistance Level | $183.21 | $49.44 |
| Average True Range (ATR) | 3.52 | 0.65 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 3.02 | 55.69 |
American Tower owns and operates about 150,000 wireless towers throughout the US, Asia, Latin America, Europe, and Africa. It also owns and/or operates 30 data centers in 11 US markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market generated by the top few mobile carriers. The company operates more than 40,000 towers in the US, which accounted for about half of total revenue in 2024. Outside the US, American Tower operates about 47,000 towers in Latin America (dominated by Brazil), 32,000 towers in Europe, and 27,000 towers in Africa. American Tower operates as a REIT.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.